Interferon-gamma upregulates MUC1 expression in haematopoietic and epithelial cancer cell lines, an effect associated with MUC1 mRNA induction

European Journal of Cancer

Volumn 39, Issue 3, 2003, Pages 397-404

  Reddy, P K ^a   Gold, D V ^a   Cardillo, T M ^a   Goldenberg, D M ^a   Li, H ^a   Burton, J D ^a  

^a CENTER FOR MOLECULAR MEDICINE AND IMMUNOLOGY   (United States)

Author keywords

Induction; Interferon; MA5; Monoclonal antibody; MUC1; Receptor

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; INTERFERON RECEPTOR; MUCIN 1;

ARTICLE; BINDING AFFINITY; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG POTENCY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IMMUNOTHERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ANTINEOPLASTIC AGENTS; BINDING SITES; CA-15-3 ANTIGEN; CELL LINE; HEMATOPOIETIC STEM CELLS; HUMANS; INTERFERON ALFA-2A; INTERFERON TYPE II; NEOPLASMS, GLANDULAR AND EPITHELIAL; PROTEIN BINDING; RECEPTORS, INTERFERON; RNA, MESSENGER; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0037306396     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(02)00700-1     Document Type: Article

References (35)

1. Berger J.T., Voynow J.A., Peters K.W., Rose M.C. Respiratory carcinoma cell lines. MUC genes and glycoconjugates. Am. J. Respir. Cell Mol. Biol. 20:1999;500-510.
2. Cornberg M., Enss M.L., Makkink M.K.et al. Variation of human mucin gene expression in gastric cancer cell lines and gastric mucous cell primary cultures. Eur. J. Cell. Biol. 78:1999;832-841.
3. Copin M.C., Devisme L., Buisine M.P.et al. From normal respiratory mucosa to epidermoid carcinoma. expression of human mucin genes Int. J. Cancer. 86:2000;162-168.
4. Dion A.S., Smorodinsky N.I., Williams C.J., Wreschner D.H., Major P.P., Keydar I. Recognition of peptidyl epitopes by polymorphic epithelial (PEM)-specific monoclonal antibodies. Hybridoma. 10:1991;595-610.
5. Gendler S.J., Burchell J.M., Duhig T.et al. Cloning of partial cDNA encoding differentiation and tumor-associated mucin glycoproteins expressed by human mammary epithelium. Proc. Nat. Acad. Sci. USA. 84:1987;6060-6064.
6. Siddiqui J., Abe M., Hayes D., Shani E., Yunis E., Kufe D. Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen. Proc. Nat. Acad. Sci. USA. 85:1988;2320-2323.
7. Ligtenberg M.J.L., Vos H.L., Gennissen A.M.C., Hilkens J. Episialin, a carcinoma-associated mucin, is generated by a polymorphic gene encoding splice variants with alternative amino termini. J. Biol. Chem. 265:1990;5573-5578.
8. Lan M.S., Hollingsworth M.A., Metzgar R.S. Molecular characterization of a mucin-type antigen associated with human pancreatic cancer. The DU-PAN-2 antigen. J. Biol. Chem. 262:1987;12863-12870.
9. Lan M.S., Batra S.K., Qi W.-N., Metzer R.S., Hollingsworth M.A. Cloning and sequencing of a human pancreatic tumor mucin cDNA. J. Biol. Chem. 144:1990;15294-15299.
10. Gendler S.J., Spicer A.P., Lalani E.N.et al. Structure and biology of a carcinoma-associated mucin, MUC1. Am. Rev. Respir. Dis. 144:1991;S42-S47.
11. Nishimori I., Perini F., Mountjoy K.P.et al. N-Acetylgalactosamine glycosylation of MUC1 tandem repeat peptides by pancreatic cell extracts. Cancer Res. 54:1994;3738-3744.
12. Delsol G., Gatter K.C., Stein H.et al. Human lymphoid cells express epithelial membrane antigen. implications for diagnosis of human neoplasms Lancet. 2:1984;1124-1129.
13. Duperry C., Klein B., Durie G.M.et al. Phenotype analysis of human myeloma cell lines. Blood. 73:1989;566-569.
14. Takahashi T., Makiguchi Y., Hinoda Y.et al. Expression of MUC1 on myeloma cells and induction of HLA-unrestricted CTL against MUC1 from a multiple myeloma patient. J. Immunol. 153:1994;2102-2109.
15. Delsol G., Al Saati T., Gatter K.C.et al. Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis. Am. J. Pathol. 130:1988;59-70.
16. Brossart P., Schneider A., Dill P.et al. The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes. Cancer Res. 61:2001;6846-6850.
17. Chittal S.M., Delsol G. The interface of Hodgkin's disease and anaplastic large cell lymphoma. Cancer Surv. 30:1997;87-105.
18. Burton J., Mishina D., Cardillo T.et al. Epithelial mucin-1 (MUC1) expression and MA5 anti-MUC1 monoclonal antibody targeting in multiple myeloma. Clin. Cancer Res. 5:1999;3065s-3072s.
19. 111In-labeled monoclonal antibody (MA5) against a mucin-like antigen. Cancer Res. 50:1990;927s-931s.
20. Bombardieri E., Cocciolo M.G., Valtolina M.et al. Effects of alpha, beta and gamma recombinant interferons on CEA production from HT-29 human colon adenocarcinoma cell line. J. Biol. Regul. Homeost. Agents. 1:1987;133-142.
21. Guadagni F., Schlom J., Johnston W.W.et al. Selective interferon-induced enhancement of tumor-associated antigens on a spectrum of freshly isolated human adenocarcinoma cells. J. Natl. Cancer Inst. 81:1989;502-512.
22. Toth C.A., Thomas P. The effect of interferon treatment on 14 human colorectal cancer cell lines. growth and carcinoembryonic antigen secretion in vitro J. Interferon Res. 10:1990;579-588.
23. Kuhn J.A., Beatty B.G., Wong J.Y.C.et al. Interferon enhancement of radioimmunotherapy for colon carcinoma. Cancer Res. 51:1991;2335-2339.
24. 131I-CC49) when given in combination with gamma-interferon. Cancer Res. 53:1993;600-608.
25. Greiner J.W., Guadagni F., Goldstein D.et al. Evidence for the elevation of serum carcinoembryonic antigen and tumor-associated glycoprotein-72 levels in patients administered interferons. Cancer Res. 51:1991;4155-4163.
26. Greiner J.W., Guadagni F., Goldstein D.et al. Intraperitoneal administration of interferon-gamma to carcinoma patients enhances expression of tumor-associated glycoprotein-72 and carcinoembryonic antigen on malignant ascites cells. J. Clin. Oncol. 10:1992;735-746.
27. Clark S., McGuckin M.A., Hurst T., Ward B.G. Effect of interferon-gamma and TNF-alpha on MUC1 mucin expression in ovarian carcinoma cell lines. Dis. Markers. 12:1994;43-50.
28. Sgagias M.K., Nieroda C., Yannelli J.R., Cowan K.H., Danforth D.N. Upregulation of DF3, in association with ICAM-1 and MHC class II by IFN-gamma in short-term human mammary carcinoma cell cultures. Cancer Biother. Radiopharm. 11:1996;177-185.
29. Gaemers I.C., Vos H.L., Volders H.H., van Der Valk S.W., Hilkens J. A STAT-responsive element in the promoter of the episialin/MUC1 gene is involved in its overexpression in carcinoma cells. J. Biol. Chem. 276:2001;6191-6199.
30. Gold D.V., Lew K., Malinak M., Cardillo T. Characterization of monoclonal antibody PAM4 reactive with a pancreatic cancer mucin. Int. J. Cancer. 57:1994;204-210.
31. Chizzonite R., Truitt T., Desai B.B.et al. IL-12 Receptor. I. Characterization of the receptor on PHA-activated human lymphoblasts J. Immunol. 148:1992;3117-3124.
32. Chomczynski P., Mackey K. Substitution of chloroform by bromo-chloropropane in the single-step method of RNA isolation. Anal. Biochem. 225:1995;163-164.
33. 131I-labeled monoclonal antibody CC49 in breast cancer. a Phase II Trial Clin. Cancer Res. 3:1997;1547-1555.
34. 131I-labeled high affinity CC49 monoclonal antibody therapy in patients with metastatic prostate cancer. Clin. Cancer Res. 5:1999;3254s-3258s.
35. Slovin S.F., Scher H.I., Divgi C.R.et al. Interferon-gamma and monoclonal antibody 131I-labeled CC49. outcomes in patients with androgen-independent prostate cancer Clin. Cancer Res. 4:1998;643-651.